Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

May 31, 2000

Study Completion Date

April 30, 2006

Conditions
Atrial Fibrillation
Trial Locations (17)

12208

Stratton VA Medical Center, Albany

13210

Syracuse VA Medical Center, Syracuse

45220

Dept. of Veterans Affairs Medical Center-Cincinnati, Cincinnati

46202

Roudebush VAMC, Indianapolis

52246

Iowa City VAMC, Iowa City

57117

Royal C Johnson VAMC, Sioux Falls

60141

Hines VAMC, Hines

68105

Omaha VAMC, Omaha

68510

Greater NE Healthcare System, Lincoln

70146

New Orleans VAMC, New Orleans

72205

Central Arkansas Veterans Healthcare System, Little Rock

75216

Dallas VAMC, Dallas

76504

Central Texas Veterans Healthcare System, Temple

80220

Denver VAMC, Denver

85012

Carl T. Hayden VAMC, Phoenix

02130

Boston VA Medical Center, Boston

03104

VAMC Manchester, Manchester

All Listed Sponsors
lead

US Department of Veterans Affairs

FED

NCT00075985 - Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist | Biotech Hunter | Biotech Hunter